Maxipirin (Acetylsalicylic Acid)

Acetylsalicylic acid irreversibly blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, preventing the conversion of arachidonic acid into prostaglandins and thromboxane A₂. The resulting decrease in prostaglandins reduces pain, fever and inflammation, while reduced thromboxane A₂ limits platelet aggregation, giving the drug its antiplatelet activity.

The appropriate dose of Maxipirin is determined by the prescribing healthcare professional based on the specific indication, patient age, weight and clinical condition. Dosage regimens may differ for pain relief, fever management, anti‑inflammatory therapy or cardiovascular prophylaxis, and should always follow the prescriber’s instructions and local labeling.

Maxipirin is classified as pregnancy category D, indicating potential risk to the fetus, especially in the third trimester due to possible effects on the fetal cardiovascular system. Use during pregnancy is generally avoided unless clearly needed. Limited data are available for breastfeeding; caution is advised and a healthcare provider should evaluate the risk‑benefit ratio.

To place an order, submit an enquiry on the Maxipirin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature requirements) and necessary import documentation.

Maxipirin is a generic formulation of acetylsalicylic acid, offering the same pharmacological profile as branded aspirin products. Differences may lie in manufacturing standards, excipients, packaging or regulatory approvals. Clinically, efficacy and safety are comparable when used at equivalent doses, though individual patient tolerance to specific formulations can vary.

Maxipirin should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. Do not store in damp or excessively hot environments, as this may affect tablet integrity.

Maxipirin is taken orally, usually with a full glass of water. It may be swallowed with or without food, although taking it with food can lessen gastrointestinal discomfort. The tablet should not be crushed or chewed unless specifically instructed by a healthcare professional.

The most serious adverse events include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, and, in rare cases, Reye’s syndrome in children with viral infections. Additionally, increased bleeding risk can occur when combined with anticoagulants or other antiplatelet agents, requiring careful monitoring.

Maxipirin should be avoided in individuals with a known hypersensitivity to aspirin or other NSAIDs, those with active gastrointestinal ulcer disease, severe renal or hepatic impairment, and in the third trimester of pregnancy. Patients on anticoagulant therapy or with bleeding disorders should consult a physician before use.